[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

August 2019 - July 1959

Decade

Year

Issue

May 2016, Vol 73, No. 5, Pages 427-536

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):427. doi:10.1001/jamapsychiatry.2015.1624
Viewpoint

True Evidence-Based Care for Posttraumatic Stress Disorder in Military Personnel and Veterans

Abstract Full Text
JAMA Psychiatry. 2016;73(5):431-432. doi:10.1001/jamapsychiatry.2015.2879

This Viewpoint discusses true evidence-based practice and using it to personalize treatment for military veterans and servicemembers with posttraumatic stress disorder.

The Meaning of Evidence-Based Treatments for Veterans With Posttraumatic Stress Disorder

Abstract Full Text
JAMA Psychiatry. 2016;73(5):433-434. doi:10.1001/jamapsychiatry.2015.2878

This Viewpoint suggests that the assertion that prolonged exposure or cognitive processing therapy should be the dominant evidence-based treatments for war-related PTSD is simplistic and may at times be unhelpful or contraindicated.

Changing the Direction of Suicide Prevention Research: A Necessity for True Population Impact

Abstract Full Text
JAMA Psychiatry. 2016;73(5):435-436. doi:10.1001/jamapsychiatry.2016.0001

This Viewpoint reports that the direction of suicide prevention research must change if more lives are to be saved.

Editorial

Meeting the Growing Need for Heroin Addiction Treatment

Abstract Full Text
JAMA Psychiatry. 2016;73(5):437-438. doi:10.1001/jamapsychiatry.2016.0139

Deep Brain Stimulation for Depression: Keeping an Eye on a Moving Target

Abstract Full Text
JAMA Psychiatry. 2016;73(5):439-440. doi:10.1001/jamapsychiatry.2016.0173

Predicting Schizophrenia

Abstract Full Text
JAMA Psychiatry. 2016;73(5):441-442. doi:10.1001/jamapsychiatry.2016.0138

Genome-wide Significant Associations for Cannabis Dependence Severity: Relevance to Psychiatric Disorders

Abstract Full Text
JAMA Psychiatry. 2016;73(5):443-444. doi:10.1001/jamapsychiatry.2016.0046

Maps of the Development of the Brain’s Functional Architecture: Could They Provide Growth Charts for Psychiatry?

Abstract Full Text
JAMA Psychiatry. 2016;73(5):445-446. doi:10.1001/jamapsychiatry.2016.0140
Original Investigation

Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):447-455. doi:10.1001/jamapsychiatry.2016.0109

The SALOME randomized clinical trial tests if injectable hydromorphone is noninferior to injectable diacetylmorphine in reducing illicit heroin use after 6 months of intervention.

Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):456-464. doi:10.1001/jamapsychiatry.2016.0152

This randomized clinical trial evaluates the effects of deep brain stimulation in patients with treatment-resistant depression and, in a crossover design, compares active and sham phases for possible detection of placebo effects.

Observed Cognitive Performance and Deviation From Familial Cognitive Aptitude at Age 16 Years and Ages 18 to 20 Years and Risk for Schizophrenia and Bipolar Illness in a Swedish National Sample

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):465-471. doi:10.1001/jamapsychiatry.2016.0053

This cohort study determines whether the developmental processes that predispose to schizophrenia are better reflected by the observed cognitive performance in adolescence or the deviation of that performance from an individual’s familial cognitive aptitude.

Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks

Abstract Full Text
free access has audio
JAMA Psychiatry. 2016;73(5):472-480. doi:10.1001/jamapsychiatry.2016.0036

This genome-wide association study assesses analyses from 3 studies of substance use disorder genetics to identify DSM-IV criteria for cannabis dependence in a large African American and European American cohort.

Growth Charting of Brain Connectivity Networks and the Identification of Attention Impairment in Youth

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):481-489. doi:10.1001/jamapsychiatry.2016.0088

This study uses data from the Philadelphia Neurodevelopmental Cohort to evaluate the charting of brain intrinsic connectivity network patterns to serve as a measure of attention functioning in youth.

N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):490-496. doi:10.1001/jamapsychiatry.2016.0060

This randomized clinical trial evaluates the use of N-acetylcysteine in short-term treatment of skin-picking disorder.

Evidence for Genetic Overlap Between Schizophrenia and Age at First Birth in Women

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):497-505. doi:10.1001/jamapsychiatry.2016.0129

This investigation uses multiple independent genome-wide association study data sets to determine if there is a genetic association between schizophrenia and age at first birth using genetically informative but independently ascertained data sets.

Association of DNA Methylation Differences With Schizophrenia in an Epigenome-Wide Association Study

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):506-514. doi:10.1001/jamapsychiatry.2016.0144

This epigenome-wide association study examines differentially methylated positions across the genome in blood-derived DNA samples in a discovery and a replication set.

Structural Brain Abnormalities in Youth With Psychosis Spectrum Symptoms

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):515-524. doi:10.1001/jamapsychiatry.2015.3463

Using a subsample of individuals from the Philadelphia Neurodevelopmental Cohort, this study investigates the presence of structural brain abnormalities in youth with psychosis spectrum symptoms.

Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):525-531. doi:10.1001/jamapsychiatry.2016.0004

This prospective cohort study of black and white community-dwelling older adults in the Health, Aging, and Body Composition study investigates the association between trajectories of depressive symptoms and risk of dementia in older adults.

Comment & Response

NESARC Findings on Increased Prevalence of Marijuana Use Disorders—Consistent With Other Sources of Information

Abstract Full Text
JAMA Psychiatry. 2016;73(5):532. doi:10.1001/jamapsychiatry.2015.3158

NESARC Findings on Increased Prevalence of Marijuana Use Disorders—Reply: Consistent With Other Sources of Information

Abstract Full Text
JAMA Psychiatry. 2016;73(5):532-533. doi:10.1001/jamapsychiatry.2016.0244

Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking Methylphenidate

Abstract Full Text
JAMA Psychiatry. 2016;73(5):533-534. doi:10.1001/jamapsychiatry.2016.0049

Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking Methylphenidate—Reply

Abstract Full Text
JAMA Psychiatry. 2016;73(5):534-535. doi:10.1001/jamapsychiatry.2016.0051

Premature Mortality and Schizophrenia—The Need to Heal Right From the Start

Abstract Full Text
JAMA Psychiatry. 2016;73(5):535-536. doi:10.1001/jamapsychiatry.2015.3432

Genomic Approaches to Phenotype Prediction

Abstract Full Text
JAMA Psychiatry. 2016;73(5):536. doi:10.1001/jamapsychiatry.2016.0031
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2016;73(5):430. doi:10.1001/jamapsychiatry.2015.1625
×